AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD)[1].
Molecular Weight:
467.50
Purity:
99.71
CAS Number:
[319460-94-1]
Formula:
C26H22FN7O
Target:
VEGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted